259 related articles for article (PubMed ID: 21782517)
1. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
Allain JP; Bianco C; Blajchman MA; Brecher ME; Busch M; Leiby D; Lin L; Stramer S
Transfus Med Rev; 2005 Apr; 19(2):110-26. PubMed ID: 15852240
[TBL] [Abstract][Full Text] [Related]
2. [Photochemical inactivation of pathogens in platelets and plasma: five years of clinical use in routine and hemovigilance. Towards a change of paradigm in transfusion safety].
Cazenave JP
Transfus Clin Biol; 2011 Apr; 18(2):53-61. PubMed ID: 21474358
[TBL] [Abstract][Full Text] [Related]
3. Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.
Webert KE; Cserti CM; Hannon J; Lin Y; Pavenski K; Pendergrast JM; Blajchman MA
Transfus Med Rev; 2008 Jan; 22(1):1-34. PubMed ID: 18063190
[TBL] [Abstract][Full Text] [Related]
4. Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries.
Drew VJ; Barro L; Seghatchian J; Burnouf T
Blood Transfus; 2017 Oct; 15(6):512-521. PubMed ID: 28488960
[TBL] [Abstract][Full Text] [Related]
5. Impact of production methods and storage conditions on extracellular vesicles in packed red blood cells and platelet concentrates.
Ebeyer-Masotta M; Eichhorn T; Fischer MB; Weber V
Transfus Apher Sci; 2024 Apr; 63(2):103891. PubMed ID: 38336556
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bacterial safety approaches of platelet blood concentrates: bacterial screening and pathogen reduction.
Rezvany MR; Moradi Hasan-Abad A; Sobhani-Nasab A; Esmaili MA
Front Med (Lausanne); 2024; 11():1325602. PubMed ID: 38651065
[TBL] [Abstract][Full Text] [Related]
7. Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™.
Irsch J; Lin L
Transfus Med Hemother; 2011; 38(1):19-31. PubMed ID: 21779203
[TBL] [Abstract][Full Text] [Related]
8. Routine results of an algorithm for managing the production of blood components.
Pérez-Aliaga AI; Ayerra I; Sánchez-Guillén J; López FJ; Puente F; Aranda A; Domingo JM; Garcés C
Vox Sang; 2024 Jun; 119(6):541-547. PubMed ID: 38410835
[TBL] [Abstract][Full Text] [Related]
9. The role and importance of epidemiology in transfusion medicine.
Politis C; Vuk T; Richardson C; Politi L; Garraud O
Transfus Clin Biol; 2024 May; 31(2):108-113. PubMed ID: 38218342
[TBL] [Abstract][Full Text] [Related]
10. A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data.
Berg P; Heiden M; Müller S; Meyer B; Witzenhausen C; Ruppert-Seipp G; Kehr S; Funk MB
Vox Sang; 2024 Jun; ():. PubMed ID: 38889998
[TBL] [Abstract][Full Text] [Related]
11. Updated review of blood culture contamination.
Hall KK; Lyman JA
Clin Microbiol Rev; 2006 Oct; 19(4):788-802. PubMed ID: 17041144
[TBL] [Abstract][Full Text] [Related]
12. Emerging Pathogens - How Safe is Blood?
Schmidt M; Geilenkeuser WJ; Sireis W; Seifried E; Hourfar K
Transfus Med Hemother; 2014 Feb; 41(1):10-7. PubMed ID: 24659943
[TBL] [Abstract][Full Text] [Related]
13. Characterization of transfusion-relevant bacteria reference strains in a lyophilized format.
Prax M; McDonald CP; Bekeredjian-Ding I; Cloutier M; Gravemann U; Grothaus A; Krut O; Mpumlwana X; O'Flaherty N; Satake M; Stafford B; Suessner S; Vollmer T; Ramirez-Arcos S;
Vox Sang; 2024 May; ():. PubMed ID: 38754952
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for Packaging, Transport, and Storage of Source Cells for Organoids.
Lee S; Kwon D; Lee HB; Jeon S; Park C; Kim TS; Lee JH; Oh IU; Ahn SJ
Int J Stem Cells; 2024 May; 17(2):113-119. PubMed ID: 38735854
[TBL] [Abstract][Full Text] [Related]
15. Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates.
Seghatchian J; Hervig T; Putter JS
Transfus Apher Sci; 2011 Aug; 45(1):75-84. PubMed ID: 21782517
[TBL] [Abstract][Full Text] [Related]
16. Pathogen-reduction systems for blood components: the current position and future trends.
Seghatchian J; de Sousa G
Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
[TBL] [Abstract][Full Text] [Related]
17. Bacterial detection of platelets: current problems and possible resolutions.
Blajchman MA; Beckers EA; Dickmeiss E; Lin L; Moore G; Muylle L
Transfus Med Rev; 2005 Oct; 19(4):259-72. PubMed ID: 16214015
[TBL] [Abstract][Full Text] [Related]
18. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
Corash L
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
[TBL] [Abstract][Full Text] [Related]
19. Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop.
Klein HG; Glynn SA; Ness PM; Blajchman MA;
Transfusion; 2009 Jun; 49(6):1262-8. PubMed ID: 19392769
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
